Hostname: page-component-77f85d65b8-v2srd Total loading time: 0 Render date: 2026-03-30T14:12:18.270Z Has data issue: false hasContentIssue false

Efficacy of continuous UV-C222 exposure of Candida auris, methicillin-resistant Staphylococcus aureus, and T1 bacteriophage at two soil levels in hospital patient rooms

Published online by Cambridge University Press:  26 March 2026

Richard L. Vincent
Affiliation:
Division of General Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, USA
Stephanie H. Factor
Affiliation:
Department of Medicine, Division of Infectious Diseases, Department of Obstetrics, Gynecology, and Reproductive Medicine, Division of Maternal and Child Health, Icahn School of Medicine at Mount Sinai, New York, USA Department of Medicine, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, USA
Laura Rivera Boudla
Affiliation:
Icahn School of Medicine at Mount Sinai, New York, USA
David Atkinson
Affiliation:
MRD Lighting, Queens, Long Island City, USA
James J. McDevitt*
Affiliation:
Department of Global, Environmental, and Occupational Health, University of Maryland, College Park, USA
Bernard C. Camins
Affiliation:
Department of Medicine, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, USA
*
Corresponding author: James J. McDevitt; Email: jmcdevi1@umd.edu
Rights & Permissions [Opens in a new window]

Abstract

Introduction:

The spread of Candida auris (C. auris), methicillin-resistant Staphylococcus aureus (MRSA) and various viruses in healthcare settings is of global concern. Far-UV-C222 reduces the concentration of microorganisms in laboratory settings and can be used directly in patient care rooms at doses safe for human eyes and skin. The effectiveness of UV-C222 inactivation of C. auris, MRSA and T1 bacteriophage (a viral surrogate) in a hospital setting was studied.

Methods:

A partially blinded, cross-over study was conducted of two conditions: intervention, active UV and control, no UV. C. auris, MRSA and T1 bacteriophage were inoculated and dried onto stainless steel disc carriers at two soil levels, (0.03% BSA and 5.0% CBS), and placed at 24 locations in two unoccupied, two-bed patient rooms. UV-C222 luminaires were placed behind the head of each bed and one in the bathroom for both study rooms. Simultaneous 24-h exposures for both rooms were in random order. Pathogens were processed for cultures.

Results:

UV-C222 doses exposing the discs ranged from a low of 5 mJ/cm2 to high 637 mJ/cm2. Under treatment conditions, MRSA showed a 1.0 log reduction in 0.03% soil, C. auris showed a 2.6 log reduction in 0.03% soil and a 1.0 log reduction in 5.0% soil and T1 bacteriophage showed a 0.6 log reduction in 0.03% soil.

Conclusions:

In patient rooms, continuous UV-C222 exposure showed decreased concentrations of C. auris (low and high soil), MRSA (low soil), and T1 (low soil). Studies are needed to determine benefits in occupied settings.

Information

Type
Original Article
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Copyright
© The Author(s), 2026. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America

Introduction

Annually, 2.8 million antimicrobial-resistant infections occur in the United States, and more than 35,000 people die as a result. 1 Environmental surfaces are recognized as points of pathogen transmission. Reference Jinadatha, Navarathna and Negron-Diaz2 In healthcare, standard, and enhanced surface disinfection practices are applied to reduce potential pathogen transmission at various soil loads; however, the effectiveness of these practices to reduce hospital-associated infections in patients remains poorly understood.

Even though environmental services personnel complete daily manual disinfection, there can be buildup of soiled surfaces between scheduled disinfection times due to recontamination from pathogen-colonized patients and spread by HCWs. Reference Christenson, Cronk and Atkinson3 Studies have been conducted to better understand the impact of standard disinfection plus additional disinfection methods. Reference Anderson, Chen and Weber4 Germicidal UV covering the UV-C200–280 spectrum has shown to be an important adjunct to manual environmental disinfection, primarily at UV-C254 in elimination of pathogens. 5,Reference Boyce and Donskey6

The use of mobile, whole-room, high-intensity UV-C254 sources in unoccupied hospital patient rooms after terminal disinfection has been proposed as a quick and effective way to decontaminate surfaces that may have been thoroughly disinfected. Reference Vincent, Rudnick, McDevitt and Wallach7Reference Cadnum, Shaikh and Piedrahita9 However, direct, high intensity application of UV-C254 is not practical throughout the patient’s admission due to exceeding the allowable human safety exposure limits for eye and skin tissue. This issue leads to the question, “Can built-in far UV-C luminaires placed in an occupied room provide a continuous, safe and effective, far UV-C 200–235 dose to significantly decrease microbial load between terminal disinfection leading to better health outcomes?”

To determine the effectiveness of 24-hour continuous far-UV-C exposure to inactivate microbes on environmental surfaces, we used filtered, Krypton Chloride excimer lamps with a primary wavelength of UV-C222. Our test pathogens (Candida Auris (C. auris), methicillin-resistant-Staphylococcus Aureus (MRSA), and T1 bacteriophage (T1 Phage) a viral surrogate) are representative of microbes of interest to the hospital infection control community and span a range of susceptibility to inactivation by traditional UV-C254. Reference Sobhani, Zhu, Vincent, Costa and Srebric10Reference Baede, David and Andrasevic16 We studied the impact of soiled surfaces, by simulating high and low soil levels.

Methods and material

This was a partially blinded, cross over study of two conditions. The intervention condition consisted of exposure from far-UV-C222 MTL3 luminaires (Myna Life Technology, Oakland, CA) emitting UV-C222 for 24 hours. In the control condition, the specimens were exposed to far-UV-C222 MTL3 luminaires that were turned on but emitted no UV for 24 hours. The reference microbiology lab personnel were blinded as to which arm the inoculated discs were assigned. The study was conducted in two double occupancy patient rooms in an unoccupied unit of a hospital in New York City (Figure 1). For the first 24 hours, one room was exposed to far-UV-C222, the intervention condition, and the other room received no UV radiation, the control condition. On the second day, the conditions were reversed.

Figure 1. Illustrative room layout with far-UV-C222 luminaires placed for the study by each of 2 beds (A and B) in the patient rooms and in each bathroom.

Lighting software (Visual, Acuity Brands Lighting, Conyers, GA) was used to model the available luminaires’ placement in each room (Figure S-1), one luminaire was placed behind the head of each bed (total 4 luminaires) and one luminaire was place in each bathroom above the doorframe (total 2 luminaires) (Figure 1). These locations were chosen to maximize the amount of UV distributed in the room and minimize the amount of UV hitting a potential patient’s eyes. Based on previous interviews with hospital environmental services staff, 24 high touch surfaces (see Figure 2a-b) in each room were identified. All sites were directly exposed except four sites shadowed or blocked by bed position (two bed side rail control panels and two undersides of overbed tables).

Figure 2. Illustrative 3-D model of placement of 24 inoculated disc carrier clusters in room 2a and in the bathroom 2b. MLT3 UV-C 222 fixtures behind patient the other is shown in the bathroom. All sites covered were recommended by hospital environmental staff. Arrows indicate the vertical or horizontal orientation of the disc carrier clusters mounted with magnetic tape on stiff cards.

The 6 luminaires were turned on to determine the amount of UV-C222 irradiance received at each of the 24 sites in each room. Handheld calibrated radiometers, X11Optometer, UV 3737-5 Detector set at 222 nm, (Gigahertz-Optik, Türkenfeld, Germany) and Ushio Care222 UIT2400, (International Light Technologies, Peabody, MA) measured the amount of UV-C222 irradiance and the 24-hour dose was calculated.

The disc carriers (Figure S-2) inoculated with pathogens for the study were prepared by a reference lab (ResInnova, Rockville, MD) using a modified American Society for Testing and Materials (ASTM) standard quantitative disk carrier test method (ASTM E2197). 17 The test organisms used included: Candida auris (CDC#B11903), methicillin-resistant Staphylococcus aureus (MRSA) (ATCC#33591) MRSA and T1 bacteriophage (T1 Phage) (ATCC#13303B1) at low and high soil levels. The low soil level represented a contaminated surface after manual disinfection and the high soil level represented a contaminated surface between manual disinfection. For the low soil level, the organisms were suspended in modified soil of 0.03% bovine serum albumin, and for the high soil level, the organisms were suspended in solution of PBS with modified soil of 5% calf bovine serum (CBS). Reference Shangjie, Dimitrios and Min18,24 After suspending the test organisms in solution, 0.010 mL was placed and spread to within 1 mm of the edges, and dried on 20 mm stainless steel disc carriers. The reference lab prepared magnetic cases which contained one variety of test organism for each of the 6 conditions. The magnetic cases were placed on ice packs and shipped to the New York City hospital in insulated boxes. Prior to the study, the stability of specimens in low soil inoculum was conducted (see Supplemental File, S-1).

For the cross over study, prior to the study, the disc carriers inoculated with organisms were brought to room temperature over a period of 1 hour. After reaching room temperature, for the intervention condition, the disc carriers inoculated with organisms were transferred to stiff cards (Figure S-2). Each stiff card had 6 labeled circles in which magnetic tape was placed for adhesion. Each inoculated disc carrier was transferred from the magnetic cases surface to the stiff cards using decontaminated, rubber tipped AFM disc grippers (Electron Microscopy Sciences, Hatfield, PA) by study personnel wearing masks, gloves, and gown to prevent contamination (Figures S-2). For the control condition, the organism inoculated disc carriers were kept in open magnetic cases.

On day 1 of the study, 24 stiff cards with the 6 inoculated disc carriers were placed in the intervention room at the previously identified sites and 24 magnetic cases with the 6 inoculated disc carriers were placed in the control room at the previously identified sites. The luminaires in the intervention room emitted UV-C222 for 24 hours and the luminaires in the control room emitted no UV-C222 for 24 hours. In both rooms, the overhead lights in the patient room and the bathroom were turned on. The blinds in both rooms were drawn to exclude sunlight. Privacy curtains were pulled around each patient bed. The doors to the rooms were closed and locked for the full 24-hour period. On day 2 of the study, the original intervention room was designated the control condition and vice versa.

Rooms with the intervention condition were monitored for the two 24-hour periods to assure appropriate functioning of the luminaires. The control condition luminaires were measured to ensure no UV-C222 was being emitted from the sham UV lamps. Three previously described handheld radiometers with UV-C222 rated sensors were placed in the intervention room; one on each patient table (n = 2) and one on the toilet seat in the bathroom (n = 1). The three UV-C radiometer results were recorded for 24 hours.

Both rooms had additional environmental monitoring during the study. Supply air and exhaust airflow was measured in both patient rooms and bathrooms using Shortridge AMD-870 Air Data Multimeter attached to Shortridge 8,400 Series flow hood with a 2’x2’ aperture (Shortridge Instruments, Scottsdale, AZ). CO2, temperature, and relative humidity were monitored by a Wave Mini air quality monitor (Airthings, Oslo, Norway).

At the end of each 24-hour period, the stiff cards were collected from the intervention room and the magnetized cases were collected from the control room. Inoculated disc carriers on the stiff cards were returned to their original individually number magnetized cases in the same order in which they had been removed. The inoculated discs were shipped overnight to the reference lab in insulated boxes for analysis. The reference lab was blinded to condition of exposure of the individual cases. For lab processing, the organism on each disc carrier was recovered, serially diluted, and plated using standard microbiology techniques to provide quantifiable viable microbial burden.

Statistical analysis

The paired Wilcoxon signed-rank test was used to compare treated disc carriers to their corresponding control disc carriers for each of the three organisms (MRSA, C. auris, and T1 Phage) under each of the two soil levels (0.03% and 5%) because the Wilcoxon signed-rank test is best for comparing paired data which is non-normally distributed. For those comparisons in which the treated condition was significantly different from the control condition, linear regression (with both ordinary least squares and with bootstrapping with 5,000 samples) with log Colony Forming Units (CFU) of the organism as the outcome and UV-C222 dose as the exposure was done to provide a quantitative estimate of the effect of UV dose on organism kill.

A P-value of ≤ .05 was considered statistically significant. SAS software version 9.4 (SAS Institute: Cary, NC, USA, 2016) was used for all data analysis.

Results

Exposure to far-UV-C222 was significantly associated with a decreased number of CFUs of MRSA in 0.03% soil, C. auris in 0.03% soil, C. auris in 5% soil, and T1 Phage in 0.03% soil (Table 1).

Table 1. Comparison of Colony Forming Units (CFU) on treated disc carriers versus CFU on control disc carriers using Wilcoxon ranked-sum test for paired non-normally distributed data

aResults of Wilcoxon ranked-sum test for paired data non-normally distributed data.

Because the UV doses achieved for this study ranged from 5 to 637 mJ/cm,2 the log reductions noted below are for the range between 0 and 600 mJ/cm2. The linear bootstrapped regression model with log CFU of MRSA in 0.03% soil as the outcome and UV dose as the exposure showed that a dose of 600 mJ/cm2 UV-C222 is associated with a 1-log reduction in CFU of MRSA in 0.03% soil (Figure 3a). The linear bootstrapped regression model with log CFU of C. auris in 0.03% soil as the outcome and UV dose as the exposure showed that a dose of 600 mJ/cm2 UV-C222 is associated with a 2.6-log reduction in CFU of C. auris in 0.03% soil (Figure 3b). The linear bootstrapped regression model with log CFU of C. auris in 5% soil as the outcome and UV dose as the exposure showed that a dose of 600 mJ/cm2 UV-C222 resulted in a 1-log reduction in CFU of C. auris in 5% soil (Figure 3c). The linear bootstrapped regression model with log CFU of T1 Phage in 0.03% soil as the outcome and UV dose as the exposure showed that a dose of 600 mJ/cm2 UV-C222 is associated with a 0.6-log reduction in CFU of T1 Phage in 0.03% soil (Figure 3d). Again, the regression lines provide estimates; the true value of the reduction lies within the 95% CI (Figures 3a,b,c,d, Table 2).

Figure 3. Linear regression (with ordinary least with squares and 5,000 bootstrapped samples) with UV dose as the exposure and log CFU of: a) MRSA in 0.03% soil as the outcome. b) Candida auris in 0.03% soil as the outcome. c) Candida auris in 5% soil as the outcome. d) T1 Phage in 5% soil as the outcome.

Table 2. Results from ordinary least squares and 5000 bootstrapped sample linear regression with log CFU of organisms as the outcome and UV-C222 dose (mJ/cm2)

OLS: based on ordinary least squares analysis; CL: confidence limits; BOOT: based on 5000 bootstrapped samples.

The calculated amount of UV-C222 dose (measured irradiance in µW/cm2 X 86,400 seconds/day) for each of the 24 sites in each room is presented in Supplementary Table 2. Monitoring of the UV-C emitted during the study did not show any lapses in output during the 24-h exposures as recorded internally by the radiometer or by direct link to a computer. Variation in UV-C222 dose at different locations was attributed to distance from the MLT3 luminaire and direct line of sight exposure of inoculated disc carriers vs. blocked or reflected. For example, some inoculated disc carriers were fixed under the patient overbed table which received minimal dose.

Supplemental Table 2 summarizes UV continuous measurements during each experiment.

Air exchange rates for the rooms varied from 4 ACH to 3 ACH.

During the experiments normal winter prevalent conditions were 71–72 °F and low RH from 44–45%.

Discussion

Far-UV emitting technology in the UV-C200–235 spectrum is antimicrobial, inactivating pathogens in air and liquid suspensions. Reference Edie19,Reference Ma20 Further, far-UV-C200–235 is shorter in wavelength than UV-C254 limiting penetration of human tissue, both skin and eyes. Reference Görlitz, Justen and Rochette21 Recently the American Council of Governmental Industrial Hygienists (ACGIH) updated their guidance which previously allowed a Threshold Limit Value (TLV) of 23 mJ/cm2 of UV-C at 222 nm (for both eyes and skin) to 160 mJ/cm2 for eyes and 479 mJ/cm2 for skin over 8 hours. 22 This ACGIH TLV change allows for higher irradiance levels and associated inactivation of pathogens, with lower health effects compared to the more commonly used UV-C254. However, the lack of data on effectiveness of far-UV-C technology in real-world settings has limited its use.

The non-penetrating nature of Far-UV-C200–235 may limit its ability to penetrate and reduce microbial loads for surfaces soiled with biofilms. Environmental biofilms either hydrated or dry can act as protective nutritional reservoirs allowing various pathogens, depending on the intrinsic nature of the microbes, to survive environmental stresses over time. Reference Maillard and Centeleghe23 Currently no germicidal UV antimicrobial efficacy standard exists. As a benchmark the EPA standard for chemical agents commonly uses a 5% organic soil level, where a reduction of 99.9% (>3 log) could be considered clinically relevant. 24

Our findings apply primarily to the selected high-touch surfaces, with largely unobstructed surfaces, in two unoccupied rooms which show that exposure to UV-C222 decreased survival of MRSA, C. auris, and T1 Phage at 0.03% soil (condition consistent with manual disinfection) and C. auris at 5% soil (condition consistent with no disinfection). The study was conducted in real hospital rooms as opposed to a controlled environment in a laboratory. Compared to organism without exposure to UV-C222, 600 mJ/cm2 of UV-C222 was associated with a 1-log CFU decrease of MRSA in 0.03% soil, a 2.6-log decrease of C. auris in 0.03% soil, and a 1-log decrease of C. auris in 5% soil. Compared with no exposure to UV-C222, 600 mJ of UV-C222 was associated with a 0.6-log reduction of T1 Phage.

To date, there have not been any other studies that have evaluated the impact of UV-C222 on organisms at 0.03% soil in a real-world setting. Future research may confirm our findings.

Memic et al. evaluated the impact of UV-C222 on MRSA and C. auris at 5% soil. Reference Memic, Kaple, Cadnum and Donskey25Reference Memic, Cadnum, Osborne, Rutala and Donskey27 In evaluating the impact of UV-C222 on MRSA, Memic et al. used a real patient room with two MTL3 luminaires in different locations compared to our study and in a much smaller room (35 m3 vs. 65 m3). They found that UV-C222 when applied with the increased intensity was associated with a decrease in CFU of MRSA. Reference Memic, Kaple, Cadnum and Donskey25 We did not find a decrease in CFU of MRSA at this soil level.

In evaluating the impact of UV-C222 on C. auris, Memic et al. used a laboratory with 2 MTL3 luminaires and in a much smaller room than our study (25 m3 vs. 65 m3). 24Reference Memic, Kaple, Cadnum and Donskey25 Similar to our study, they found that UV-C222 was associated with decrease in CFU of C. auris. Together these studies suggest that UV-C222 reliably inactivates C. auris at soil levels consistent with the absence of manual disinfection.

In our study, the impact of UV-C222 was different at different levels of soil. Ratliff et al. conducted a series of laboratory experiments to test the impact of inoculum composition on the germicidal effectiveness of UV-C254 and UV-C222. They found the presence of 222 nm UV absorbing substances (i.e., salts, sugars, proteins) and dried versus wet inoculum on surfaces can reduce the germicidal efficiency of UV-C. Reference Katherine, Michael, Ahmed, Mariela, Denise and Lukas28 Those laboratory experiments are consistent with our real-world study. Dried inoculum concentrates both the organisms and soil agent, reducing the penetration of the shortwave UV-C222. This may indicate the potential of UV-C222, as an adjunct to manual disinfection, to impact various organisms within a dried biofilm in an occupied patient room.

The impact of the decrease of organisms due to UV-C222 on health is not known. Previous researchers have suggested that a ≥3-log reduction in organisms is clinically meaningful; however, studies to demonstrate this have not been done and are needed. Reference Rutala, Kanamori, Gergen, Sickbert-Bennett and Weber29 The clinical relevance of our results cannot be determined. However, our results do show that within the limitations of room furnishings and luminaire configuration of our real-world environment, UV-C222 is associated with a decrease in organism load.

We found that C. auris was more resistant to UV-C222 inactivation than was MRSA or T1 Phage. The greater intrinsic resistance of the C. auris organism may have allowed the impact of UV-C222 to register at both soil levels over a long period of time, whereas, both MSRA and TI Phage showed less ability to survive environmental stresses and register the full impact of UV-C222.

Our study limitations included: availability of number of MLT3 luminaires to try different, more uniform distributions of UV in the unoccupied spaces, the number of surfaces to be include for these clustered inoculum-based pathogen experiments, and the degree to which microbial inoculation on carriers represent ambient conditions in occupied patient rooms. A future inoculum-based refinement would allow the control carriers to be mounted on individual stiff cards eliminating any potential modification of the microenvironment by magnetic carry cases. For this unoccupied microbial study, potential eye and skin level exposure doses were not recorded; however, in rooms to be occupied, safety assessments should be taken at eye height while seated (in chairs, beds or toilets), laying down and standing, and adjusted (if needed) before occupancy.

This study shows that as an adjunct to standard disinfection, continuous UV-C222 surface exposure may be effective for improving hygienic conditions to decrease hospital-acquired infections for patients. Further longitudinal tests with improved UV distribution and ambient organisms in occupied patient rooms with complexities of added medical equipment and extended surfaces are needed to determine the baseline levels of microbial surface contamination and the benefit of continuous UV disinfection between manual disinfection.

Supplementary material

The supplementary material for this article can be found at https://doi.org/10.1017/ice.2026.10414.

Acknowledgements

Myna Life Technology loaned the precommercial MLT3 luminaires for testing. Air exchange measurements were provided courtesy of William Palmer, (AiriA International, LLC, NY). MRD Lighting, LIC, NY allowed staging the far-UVC luminaires in their facilities prior to the study. On 10-17-23, the Internal Review Board of the Icahn School of Medicine Mount Sinai determined that this study was exempt from review since no human data was collected (IRB#23-0041).

Financial support

Ushio, Tokyo, Japan sponsored this research.

Competing interests

S.H.F., L.R.B, D.A., J.J.McD did not report a conflict of interest. B.C.C. and R.L.V. did not report a conflict of interest but reported a grant from UV Smart.

References

2023 National and State Healthcare-Associated Infections (HAI) Progress Report November 2024. CDC 2023 The Centers for Disease Control and Prevention (CDC). https://arpsp.cdc.gov/profile/national-progress-2023/united-states. Accessed 12-10-2024.Google Scholar
Jinadatha, C, Navarathna, T, Negron-Diaz, J, et al. Understanding the significance of microbiota recovered from health care surfaces. Am J Infect Control 2024;52:220224. doi: 10.1016/j.ajic.2023.11.006.CrossRefGoogle ScholarPubMed
Christenson, EC, Cronk, R, Atkinson, H et al. Evidence map and systematic review of disinfection efficacy on environmental surfaces in healthcare facilities. Int J Environ Res Public Health 2021;18:11100. doi: 10.3390/ijerph182111100.CrossRefGoogle ScholarPubMed
Anderson, DJ, Chen, LF, Weber, DJ et al. Enhanced terminal room disinfection and acquisition and infection caused by multidrug-resistant organisms and Clostridium difficile (the benefits of enhanced terminal room disinfection study): a cluster-randomised, multicentre, crossover study. Lancet 2017;389:805814. doi: 10.1016/S0140-6736(16)31588-4.CrossRefGoogle ScholarPubMed
NIOSH 2009 Tuberculosis. Environmental Control for Tuberculosis: Basic Upper-Room Ultraviolet Germicidal Irradiation Guidelines for Healthcare Settings, Department of Health and Human Services (DHHS), Centers for Disease Control and Prevention (CDC) National Institute for Occupational Safety and Health (NIOSH), DHHS (NIOSH) Publication No. 2009-105, March 2009. https://www.cdc.gov/niosh/docs/2009-105/pdfs/2009-105.pdf?id=10.26616/NIOSHPUB2009105.Google Scholar
Boyce, JM, Donskey, CJ. Understanding ultraviolet light surface decontamination in hospital rooms: a primer. Infect Control Hosp Epidemiol 2019;40:10301035.10.1017/ice.2019.161CrossRefGoogle ScholarPubMed
Vincent, RL, Rudnick, SN, McDevitt, JJ, Wallach, FR. Toward a test protocol for surface decontamination using a mobile whole-room UVGI device. Photochem Photobiol 2021;97:552559. doi: 10.1111/php.13416.CrossRefGoogle Scholar
Rutala, W, Kanamori, H, Gergen, M, Sickbert-Bennett, E, Weber, D. Inactivation of Candida auris and Candida albicans by ultraviolet-C. Infect Control Hosp Epidemiol 2020;41:S292S292. doi: 10.1017/ice.2020.868.CrossRefGoogle Scholar
Cadnum, JL, Shaikh, AA, Piedrahita, CT et al. Relative resistance of the emerging fungal pathogen candida auris and other Candida species to killing by ultraviolet light. Infect Control Hosp Epidemiol 2018;39:9496. doi: 10.1017/ice.2017.239.CrossRefGoogle ScholarPubMed
Sobhani, H, Zhu, S, Vincent, RL, Costa, HD, Srebric, J. A literature review of ultraviolet inactivation rate constants (k-values) for the most frequently studied microorganisms (1854-RP). Sci Technol Built Environ 2025;31:604625. doi: 10.1080/23744731.2025.2487390.CrossRefGoogle Scholar
Bhargava, A, Klamer, K, Sharma, M, Ortiz, D, Saravolatz, L. Candida auris: a continuing threat. Microorganisms 2025;13:652. doi: 10.3390/microorganisms13030652.CrossRefGoogle ScholarPubMed
Shoaib, M, Aqib, AI, Muzammil, I et al. MRSA compendium of epidemiology, transmission, pathophysiology, treatment, and prevention within one health framework. Front Microbiol 2023;13:1067284. doi: 10.3389/fmicb.2022.1067284.CrossRefGoogle ScholarPubMed
Cristina, ML, Spagnolo, AM, Sartini, M. An overview on Candida auris in healthcare settings. J Fungi (Basel) 2023;9dddddd:913. doi: 10.3390/jof9090913.CrossRefGoogle ScholarPubMed
De Gaetano, S, Midiri, A, Mancuso, G, Avola, MG, Biondo, C. Candida auris outbreaks: current status and future perspectives. Microorganisms 2024;12:927. doi: 10.3390/microorganisms12050927.CrossRefGoogle ScholarPubMed
Centers for Disease Control and Prevention (CDC) C. auris:Research and Development | Candida auris (C. auris) website. https://www.cdc.gov/candida-auris/programs/index.html. Accessed September 9, 2025.Google Scholar
Baede, VO, David, MZ, Andrasevic, AT et al. MRSA Surveillance Worldwide Study Group (ISAC), the ESCMID Study Group for Nosocomial Infections (ESGNI), the ESCMID Study Group for Staphylococci and Staphylococcal Diseases (ESGS). MRSA surveillance programmes worldwide: moving towards a harmonised international approach. Int J Antimicrob Agents 2022;59:106538. doi: 10.1016/j.ijantimicag.2022.106538.CrossRefGoogle Scholar
ASTM International. Designation E2197. Standard Quantitative Disk Carrier Test Method for Determining Bactericidal, Virucidal, Fungicidal, Mycobactericidal, and Sporicidal Activities of Chemicals. West Conshohocken, PA: ASTM International; 2011.Google Scholar
Shangjie, L, Dimitrios, L, Min, Z. Electrospinning technologies for the delivery of biopharmaceuticals: current status and future trends. Int J Pharm 2024;651:123641. doi: 10.1016/j.ijpharm.2023.123641.Google Scholar
Edie, E. DE-UVC (222 nm) efficiently inactivates an airborne pathogen in a room-sized chamber. Sci Rep 2022;12:4373.10.1038/s41598-022-08462-zCrossRefGoogle Scholar
Ma, B. Inactivation of coronaviruses and phage Phi6 from irradiation across UVC wavelengths. Environ Sci Technol Lett 2021;8:425430.10.1021/acs.estlett.1c00178CrossRefGoogle ScholarPubMed
Görlitz, M, Justen, L, Rochette, PJ, et al. Assessing the safety of new germicidal far-UVC technologies. Photochem Photobiol 2024;100:501520. doi: 10.1111/php.13866.CrossRefGoogle ScholarPubMed
ACGIH 2022. Threshold Limit Values for Chemical Substances and Physical Agents & Biological Exposure Indices. Cincinnati, OH: ACGIH.Google Scholar
Maillard, JY, Centeleghe, I. How biofilm changes our understanding of cleaning and disinfection. Antimicrob Resist Infect Control 2023;12:95. doi: 10.1186/s13756-023-01290-4.CrossRefGoogle ScholarPubMed
United States Environmental Protection Agency (USEPA) Office of Chemical Safety and Pollution Prevention (7510P) EPA 712-C-17-004 Product Performance Test Guidelines. OCSPP 810.2200,Disinfectants for Use on Environmental Surfaces Guidance for Efficacy.Google Scholar
Memic, S, Kaple, CE, Cadnum, JL, Donskey, CJ. Evaluation of an automated wall-mounted far ultraviolet-C light technology for continuous or intermittent decontamination of Candida auris on surfaces. Pathog Immun 2024;17:156167. doi: 10.20411/pai.v9i1.683.CrossRefGoogle Scholar
Memic, S, Osborne, AO, Cadnum, JL, Donskey, CJ. Efficacy of a far-ultraviolet-C light technology for continuous decontamination of air and surfaces. Infect Control Hosp Epidemiol 2024; 45:132134. doi: 10.1017/ice.2023.159.CrossRefGoogle ScholarPubMed
Memic, S, Cadnum, JL, Osborne, A, Rutala, WA, Donskey, CJ. A novel approach for safe and automated implementation of far ultraviolet-C light decontamination in clinical areas. Antimicrob Steward Healthc Epidemiol 2024;4:e123. doi: 10.1017/ash.2024.388.CrossRefGoogle ScholarPubMed
Katherine, R, Michael, WC, Ahmed, A-H, Mariela, M, Denise, A, Lukas, O. Impact of inoculum composition on bacteria and bacteriophage UVC inactivation at 222 nm and 254 nm. Lett Appl Microbiol 2025;78:ovaf090. doi: 10.1093/lambio/ovaf090.Google Scholar
Rutala, WA, Kanamori, H, Gergen, MF, Sickbert-Bennett, EE, Weber, DJ. Susceptibility of Candida auris and Candida albicans to 21 germicides used in healthcare facilities. Infect Control Hosp Epidemiol 2019;40:380382. doi: 10.1017/ice.2019.1.CrossRefGoogle ScholarPubMed
Figure 0

Figure 1. Illustrative room layout with far-UV-C222 luminaires placed for the study by each of 2 beds (A and B) in the patient rooms and in each bathroom.

Figure 1

Figure 2. Illustrative 3-D model of placement of 24 inoculated disc carrier clusters in room 2a and in the bathroom 2b. MLT3 UV-C 222 fixtures behind patient the other is shown in the bathroom. All sites covered were recommended by hospital environmental staff. Arrows indicate the vertical or horizontal orientation of the disc carrier clusters mounted with magnetic tape on stiff cards.

Figure 2

Table 1. Comparison of Colony Forming Units (CFU) on treated disc carriers versus CFU on control disc carriers using Wilcoxon ranked-sum test for paired non-normally distributed data

Figure 3

Figure 3. Linear regression (with ordinary least with squares and 5,000 bootstrapped samples) with UV dose as the exposure and log CFU of: a) MRSA in 0.03% soil as the outcome. b) Candida auris in 0.03% soil as the outcome. c) Candida auris in 5% soil as the outcome. d) T1 Phage in 5% soil as the outcome.

Figure 4

Table 2. Results from ordinary least squares and 5000 bootstrapped sample linear regression with log CFU of organisms as the outcome and UV-C222 dose (mJ/cm2)

Supplementary material: File

Vincent et al. supplementary material

Vincent et al. supplementary material
Download Vincent et al. supplementary material(File)
File 368.5 KB